Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

30%

3 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 4
2(66.7%)
Phase 3
1(33.3%)
3Total
Phase 4(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT07019077Recruiting

Incidence of Late Haemorrhage After Invasive Gastroenterological Endoscopic Manoeuvre in Patients Treated With Anticoagulants Compared to Non-anticoagulated Patients

Role: collaborator

NCT06814899Recruiting

Use of Fosfomycin in the Treatment of Bacterial Infections

Role: lead

NCT06424925Not Yet Recruiting

Use of Artificial Intelligence (AI) to Predict Clinical Outcomes in Patients Hospitalized for COVID19 Pneumonia During the 4 Pandemic Waves

Role: lead

NCT06426212Recruiting

Use of Teicoplanin on a Three-weekly Administration in the Infectious Diseases Unit

Role: lead

NCT06334185Not Yet Recruiting

Evaluation of Vaccination for Streptococcus Pneumoniae in Adults With an Episode of Invasive Pneumococcal Infection.

Role: lead

NCT02812355Phase 4Unknown

Randomized Anticoagulation Trial in Opcab (RATIO)

Role: lead

NCT01604720Unknown

Sample Size Definition in Cochrane Hepato-Biliary Trials

Role: lead

NCT01598870Unknown

Diagnosis of Spontaneous Bacterial Peritonitis

Role: lead

NCT01432496Phase 3Terminated

Peritoneal Nebulization of Ropivacaine for Pain Control After Laparoscopic Colectomy

Role: collaborator

NCT01414842Phase 4Completed

HFR A-equilibrium on Cardiovascular Stability

Role: lead

All 10 trials loaded